IART
Integra LifeSciences Holdings
15.50$
-3.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.6% | 10.7% | 11.7% | 9.6% | 13.6% | 15.3% | 14.9% | 20.3% | 17.0% | 9.1% | 8.0% | 3.1% | |
| 6.6% | 6.7% | 7.3% | 7.5% | 7.5% | 7.2% | 8.5% | 7.8% | 7.6% | 8.0% | 8.7% | 9.3% | |
| 1.6% | 1.8% | 1.7% | 1.8% | 1.4% | 1.4% | 1.4% | 2.3% | 1.8% | 1.3% | 1.5% | 1.1% | |
| 1.5% | 5.2% | 1.3% | -3.4% | 1.4% | 0.7% | -3.2% | 8.2% | 0.1% | – | – | – | |
| -4.2% | -1.9% | -1.1% | -0.1% | 0.1% | -1.0% | -3.0% | 1.2% | -2.5% | -5.3% | -1.9% | -2.1% | |
| 4.6% | 3.8% | 4.8% | 3.7% | 5.3% | 8.9% | 4.7% | 3.1% | 3.0% | 4.3% | 6.5% | 5.8% | |
| -39.1% | -42.1% | -4.3% | -102.8% | -3.4% | -10.7% | -5.0% | -10.5% | -3.8% | -6.1% | -24.3% | -6.6% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 3.2% | 0.1% | 0.4% | 6.0% | – | – | |
| 1.6% | 25.7% | -0.5% | -0.6% | -0.5% | -0.4% | -7.3% | -0.3% | -8.0% | -17.8% | -3.3% | 0.0% | |
| 24.4% | 8.5% | -2.1% | 98.5% | -33.5% | -0.6% | 20.5% | -6.5% | -6.9% | 3.5% | 18.6% | 3.1% | |
| 26.2% | 29.3% | -1.5% | 98.4% | -12.3% | -0.6% | 8.9% | -6.4% | -16.2% | -14.9% | 14.8% | 1.7% | |
| -5.2% | -2.7% | 5.4% | 6.1% | -2.5% | 4.0% | 19.8% | 2.8% | -3.6% | -11.7% | -1.9% | -0.7% | |
| 4.0% | 6.9% | 7.0% | 6.0% | 8.3% | 6.4% | 10.2% | 17.1% | 14.0% | 4.7% | 1.6% | -2.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.